200 related articles for article (PubMed ID: 11376868)
21. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
Marks PA; Rifkind RA
Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
[TBL] [Abstract][Full Text] [Related]
22. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
Chen ZX
Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):261-4. PubMed ID: 1806345
[TBL] [Abstract][Full Text] [Related]
23. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
[TBL] [Abstract][Full Text] [Related]
24. Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process.
Marks PA; Richon VM; Kiyokawa H; Rifkind RA
Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10251-4. PubMed ID: 7937935
[TBL] [Abstract][Full Text] [Related]
25. Expression of megakaryocytic and erythroid properties in human leukemic cells.
Tani T; Ylänne J; Virtanen I
Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
[TBL] [Abstract][Full Text] [Related]
26. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
27. Bcl-XL is required for heme synthesis during the chemical induction of erythroid differentiation of murine erythroleukemia cells independently of its antiapoptotic function.
Hafid-Medheb K; Augery-Bourget Y; Minatchy MN; Hanania N; Robert-Lézénès J
Blood; 2003 Apr; 101(7):2575-83. PubMed ID: 12446462
[TBL] [Abstract][Full Text] [Related]
28. Dexniguldipine hydrochloride, a protein-kinase-C-specific inhibitor, affects the cell cycle, differentiation, P-glycoprotein levels, and nuclear protein phosphorylation in Friend erythroleukemia cells.
Patterson KK; Beckman BS; Klotz DM; Mallia CM; Jeter JR
J Cancer Res Clin Oncol; 1996; 122(8):465-75. PubMed ID: 8698746
[TBL] [Abstract][Full Text] [Related]
29. Differentiation inducers modulate cytokine signaling pathways in a murine erythroleukemia cell line.
Yamashita T; Wakao H; Miyajima A; Asano S
Cancer Res; 1998 Feb; 58(3):556-61. PubMed ID: 9458105
[TBL] [Abstract][Full Text] [Related]
30. Hexamethylene bisacetamide-induced differentiation of Friend virus-transformed murine erythroleukemia cells is associated with parallel changes in casein kinase II and guanine nucleotide exchange factor activities.
Aroor AR; Singh LP; Wahba AJ
Exp Hematol; 1995 Oct; 23(11):1204-11. PubMed ID: 7556531
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
32. Cell cycle regulatory proteins are targets for induced differentiation of transformed cells: Molecular and clinical studies employing hybrid polar compounds.
Marks PA; Richon VM; Rifkind RA
Int J Hematol; 1996 Jan; 63(1):1-17. PubMed ID: 8713572
[TBL] [Abstract][Full Text] [Related]
33. Effects of depletion of intracellular tetrahydrobiopterin in murine erythroleukemia cells.
Zhuo S; Fan S; Kaufman S
Exp Cell Res; 1996 Jan; 222(1):163-70. PubMed ID: 8549660
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of c-Jun expression and cell cycle regulatory molecules in acute myeloid leukemia cells upon CD44 ligation.
Zada AA; Singh SM; Reddy VA; Elsässer A; Meisel A; Haferlach T; Tenen DG; Hiddemann W; Behre G
Oncogene; 2003 Apr; 22(15):2296-308. PubMed ID: 12700665
[TBL] [Abstract][Full Text] [Related]
35. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
36. Two-dimensional gel electrophoretic analysis of cytoplasmic proteins from Friend erythroleukemia cells chemically induced to undergo terminal erythroid differentiation.
Mansfield BK; Mann RC; Selkirk JK
Cancer Res; 1988 Mar; 48(5):1110-8. PubMed ID: 3277706
[TBL] [Abstract][Full Text] [Related]
37. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
38. Manipulating the onset of cell cycle withdrawal in differentiated erythroid cells with cyclin-dependent kinases and inhibitors.
Matushansky I; Radparvar F; Skoultchi AI
Blood; 2000 Oct; 96(8):2755-64. PubMed ID: 11023509
[TBL] [Abstract][Full Text] [Related]
39. Terminal differentiation of normal chicken erythroid progenitors: shortening of G1 correlates with loss of D-cyclin/cdk4 expression and altered cell size control.
Dolznig H; Bartunek P; Nasmyth K; Müllner EW; Beug H
Cell Growth Differ; 1995 Nov; 6(11):1341-52. PubMed ID: 8562472
[TBL] [Abstract][Full Text] [Related]
40. Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells.
Fibach E; Reuben RC; Rifkind RA; Marks PA
Cancer Res; 1977 Feb; 37(2):440-4. PubMed ID: 264411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]